Want to see HK:3613 full AI Analyst Report?
3613 Stock Chart & Stats
HK$8.61
-HK$0.07(-0.87%)
At close: 4:00 PM EST
HK$8.61
-HK$0.07(-0.87%)
Day’s Range― - ―
52-Week RangeHK$6.21 - HK$9.72
Previous CloseN/A
Volume609.00K
Average Volume (3M)1.10M
Market Cap
HK$5.78B
Enterprise ValueHK$3.44B
Total Cash (Recent Filing)HK$2.28B
Total Debt (Recent Filing)HK$126.54M
Price to Earnings (P/E)14.7
Beta0.70
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.36%
Share Statistics
EPS (TTM)0.47
Shares Outstanding837,100,000
10 Day Avg. Volume975,850
30 Day Avg. Volume1,095,238
Financial Highlights & Ratios
PEG Ratio-0.83
Price to Book (P/B)1.69
Price to Sales (P/S)4.68
P/FCF Ratio8.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$10.50Price Target Upside21.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.6
Revenue Forecast (FY)HK$1.67B
Bulls Say, Bears Say
Bulls Say
Very Low LeverageA debt-to-equity around 0.03 indicates a conservatively financed business that can absorb shocks, fund retail expansion or product investment, and maintain dividends without refinancing stress. That balance-sheet flexibility supports durable operations and strategic optionality over months.
High And Stable MarginsConsistently strong gross and operating margins provide durable earnings power that supports reinvestment, R&D, and shareholder payouts. Healthy margins help the company withstand price competition and facilitate margin-accretive product mix shifts over a multi-month horizon.
Diversified Channels & Strong BrandA multi-channel model—manufacturing, wholesale distribution and branded retail—plus the Tong Ren Tang brand provide durable revenue diversification, pricing power, and direct consumer access. This structural mix reduces single-channel risk and supports steady cash generation.
Bears Say
Recent Revenue DeclineAn 11.4% revenue decline in 2025 signals weakening demand, pricing or mix shifts that impair scale economics. If the top-line contraction persists, it can erode operating leverage and compress margins, forcing tougher trade-offs on investment and dividends over the medium term.
Falling Return On EquityROE erosion to roughly 9.5% reflects weaker returns on the company's capital base, reducing capital efficiency. Lower ROE over several years can limit shareholder value creation, constrain reinvestment returns and indicate structural margin or competitive pressure risks ahead.
Cash-flow VolatilityIntermittent negative OCF/FCF (notably 2024) signals working-capital swings and uneven cash conversion despite profits. This volatility hurts predictability for capex, dividends, and store investment and raises reliance on the balance sheet to smooth operations in tighter periods.
Beijing Tong Ren Tang Chinese Medicine Co News
3613 FAQ
What was Beijing Tong Ren Tang Chinese Medicine Co Ltd’s price range in the past 12 months?
Beijing Tong Ren Tang Chinese Medicine Co Ltd lowest stock price was HK$6.21 and its highest was HK$9.72 in the past 12 months.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd’s market cap?
Beijing Tong Ren Tang Chinese Medicine Co Ltd’s market cap is HK$5.78B.
When is Beijing Tong Ren Tang Chinese Medicine Co Ltd’s upcoming earnings report date?
Beijing Tong Ren Tang Chinese Medicine Co Ltd’s upcoming earnings report date is Aug 07, 2026 which is in 16 days.
How were Beijing Tong Ren Tang Chinese Medicine Co Ltd’s earnings last quarter?
Beijing Tong Ren Tang Chinese Medicine Co Ltd released its earnings results on Mar 20, 2026. The company reported HK$0.194 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.194.
Is Beijing Tong Ren Tang Chinese Medicine Co Ltd overvalued?
According to Wall Street analysts Beijing Tong Ren Tang Chinese Medicine Co Ltd’s price is currently Undervalued.
Does Beijing Tong Ren Tang Chinese Medicine Co Ltd pay dividends?
Beijing Tong Ren Tang Chinese Medicine Co Ltd pays a Annually dividend of HK$0.4 which represents an annual dividend yield of 5.36%. See more information on Beijing Tong Ren Tang Chinese Medicine Co Ltd dividends here
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd’s EPS estimate?
Beijing Tong Ren Tang Chinese Medicine Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Tong Ren Tang Chinese Medicine Co Ltd have?
Beijing Tong Ren Tang Chinese Medicine Co Ltd has 837,100,000 shares outstanding.
What happened to Beijing Tong Ren Tang Chinese Medicine Co Ltd’s price movement after its last earnings report?
Beijing Tong Ren Tang Chinese Medicine Co Ltd reported an EPS of HK$0.194 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.892%.
Which hedge fund is a major shareholder of Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Currently, no hedge funds are holding shares in HK:3613
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.
3613 Stock 12 Month Forecast
Average Price Target
HK$10.50
▲(21.95% Upside)
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Tong Ren Tang Technologies Co
―
Modern Chinese Medicine Group Co. Ltd.
―
Gushengtang Holdings Limited
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―